Companies › Spero Therapeutics

Spero Therapeutics

Healthcare 📍 Cambridge, United States 👥 1001-5000 employees 💰 $63.0M raised 📅 Founded 2013

Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutic

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
1001-5000
Total Raised · Venture
$63.0M
Founded
2013
Cloud
Unknown
Email
Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
WorkspaceMicrosoft 365
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$11M $27M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / PlatformWebflow
Frontend Stack🔒 Subscribers only

Detected from Spero Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction